reports
- GlobalData Healthcare Department
Staidson (Beijing) Biopharmaceuticals Co Ltd (300204) - Financial Anal...
Staidson (Beijing) Biopharmaceuticals Co Ltd (300204) - Financial Analysis Review Summary Staidson (Beijing) Biopharmaceuticals Co Ltd (Staidson) focuses on the research, development and commercialization of biological protein products. The company’s product portfolio comprises Su peptide Health, an injection of mouse nerve growth factor; Shu Taiqing, Shu Wei Xin, Gliclazide, Nabumetone and aspirin among others. It provides its products in the form of injection, powder and capsules. GlobalD...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.